This report displays the potential drug interactions for the following 2 drugs:
- API Healthcare Paracetamol (acetaminophen)
- Theraflu Nighttime Severe Cold & Cough (acetaminophen/diphenhydramine/phenylephrine)
Interactions between your drugs
No interactions were found between API Healthcare Paracetamol and Theraflu Nighttime Severe Cold & Cough. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
API Healthcare Paracetamol
A total of
105 drugs
are known to interact with
API Healthcare Paracetamol.
-
Api healthcare paracetamol is used to treat
Pain.
Theraflu Nighttime Severe Cold & Cough
A total of
582 drugs
are known to interact with
Theraflu Nighttime Severe Cold & Cough.
Drug and food interactions
No interactions were found. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition.
This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit.
It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy,
and can have potentially adverse consequences.
The recommended maximum number of medicines in the 'acetaminophen' category to be taken concurrently is usually one.
Your list includes two medicines belonging to the 'acetaminophen' category:
- API Healthcare Paracetamol (acetaminophen)
- Theraflu Nighttime Severe Cold & Cough (acetaminophen/diphenhydramine/phenylephrine)
Note: The benefits of taking this combination of medicines may outweigh any risks associated with therapeutic duplication.
This information does not take the place of talking to your doctor.
Always check with your healthcare provider to determine if any adjustments to your medications are needed.
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
